A pilot study of ORF 8063, a new benzodiazepine in anxious alcoholic patients
Gardos, G.; Cole, J.O.; Orzack, M.H.; Pierce, A.G.; Keller, M.
Current Therapeutic Research 16(6): 628-634
1974
ISSN/ISBN: 0011-393X PMID: 4211144 Document Number: 76525
Document emailed within 1 workday
Related Documents
Rocca, P.; Ravizza, L.; Maina, G.; Bergamasco, B.; Ferrero, P. 1992: Peripheral-type benzodiazepine receptors in blood cells of anxious patients Advances in Biochemical Psychopharmacology 47: 229-233Peter, K.; Jauch, M.; Bauer, U. 1995: Study of psychopathologic-biorhythm aspects of alcoholic patients in the withdrawal phase--initial results of a pilot study Wiener Medizinische Wochenschrift 145(17-18): 454-455
Troisfontaines, B.; von Frenckell, R.; Bronckart, C.; Guiot-Goffioul, F.; Bobon, D. 1987: Open study of clotiazepam (Clozan) in ambulatory anxious patients centered on a multifactorial evaluation using the AMDP and on a study of the rebound effect Acta Psychiatrica Belgica 87(2): 215-229
Ropert, R.; Bernes, J.; Dachary, J.M. 1987: Efficacy and tolerance of alprazolam and bromazepam in flexible doses. Double-blind study in 119 ambulatory anxious patients L'Encephale 13(2): 89-95
Cohn, J.B. 1981: Multicenter double-blind efficacy and safety study comparing alprazolam, diazepam and placebo in clinically anxious patients Journal of Clinical Psychiatry 42(9): 347-351
Endo, Y. 1988: Self care and guidance of patients: nursing of alcoholic patients. Role changes within families of alcoholic patients Nursing Technique 34(16): 1896-1899
Yatsuji, S.; Hashimoto, E. 2006: Natural history of Japanese patients with non-alcoholic fatty liver disease (NAFLD), especially non-alcoholic steatohepatitis (NASH) patients with hepatocellular carcinoma (HCC) Nihon Rinsho. Japanese Journal of Clinical Medicine 64(6): 1173-1179
Gullo, L.; Casadei, R.; Campione, O.; Grigioni, W.; Marrano, D. 1995: Alcoholic liver disease in alcoholic chronic pancreatitis: a prospective study Italian Journal of Gastroenterology 27(2): 69-72
Akhmedov, V.A.; P'iannikov, V.V.; Keruchenko, A.L. 2011: Comparison of the immune response in patients with alcoholic liver disease and non-alcoholic steatohepatitis Eksperimental'naia i Klinicheskaia Gastroenterologiia 6: 22-25
Majumdar, S.K.; Shaw, G.K.; Aps, E.J.; Thomson, A.D. 1981: Alcoholic liver disease among alcoholic patients in a psychiatric hospital Practitioner 225(1362): 1833-1835
Popek, L.; Zydowicz, M. 1995: Case study of an anxious child Psychiatria Polska 29(4): 479-489
Manji, I. 1994: Managing anxious patients Journal 60(7): 591
Wensing, G.; Hoffmann, K.; Heidemann, H.T. 1993: Antipyrine elimination in patients with alcoholic and non-alcoholic cirrhosis Zeitschrift für Gastroenterologie 31(1): 15-19
Fann, W.E.; Sullivan, J.L.; Miller, R.D. 1974: Halazepam in anxious outpatients: a controlled study Current Therapeutic Research 16(12): 1281-1286
Rosenthal, S.; Harris, D.T.; Horton, J.; Glick, J.H. 1980: Phase II study of maytansine in patients with advanced lymphomas: an Eastern Cooperative Oncology Group pilot study Cancer Treatment Reports 64(10-11): 1115-1117
Sussman, N. 1993: How to manage anxious patients who are depressed Journal of Clinical Psychiatry 54 Suppl: 8
B1uchard, S.; Gauthier, J.; Laberge, B.; Plamondon, J. 1995: What psychotherapy to offer to anxious patients? L'Union Medicale du Canada 124(3): 14-19
Mestres, O.; Poca, M.ía.A.; Solana, E.; Radoi, A.; Quintana, M.; Force, E.; Sahuquillo, J. 2012: Evaluation of the quality of life of patients with a Chiari type i malformation. a pilot study in a cohort of 67 patients Revista de Neurologia 55(3): 148-156
Sladká, R.; Dostálová, J.; Haskovcová, V.; Jarosová, M.; Slánská, J.; Faltus, F.; Filip, V. 1978: Placebo controlled study with tofisopam in anxious neurosis Activitas Nervosa Superior 20(4): 245-246
Crawford, A.N.; Hawker, B.J.; Lennon, M.A. 1997: A dental support group for anxious patients British Dental Journal 183(2): 57-62